{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:42:22Z","timestamp":1785807742117,"version":"3.56.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Endocarditis occurs in approximately 10%\u201315% of patients with Staphylococcus aureus bacteremia (SAB). Short time to positivity (TTP) in blood culture flasks has been linked to endocarditis in smaller studies. This study evaluated the association between TTP and endocarditis in SAB in a large cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Adult patients with \u22651 S. aureus positive blood culture treated at a tertiary-level, 500-bed hospital in Stockholm, Sweden between 2011\u20132021 were retrospectively identified. The primary outcome was the presence of infective endocarditis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 1703 episodes of SAB (23\/1703 methicillin-resistant) in 1610 patients were included. Median age was 75 (interquartile range [IQR], 63\u201384) years and median Charlson comorbidity index score was 2 (IQR, 1\u20133). Echocardiography was performed in 1102\/1703 (65%). Thirty-day mortality was 406\/1703 (24%) and endocarditis was found in 154\/1703 (9%). Median TTP was shorter in patients with endocarditis (9 [IQR, 7\u201312] hours) compared to patients without endocarditis (13 [interquartile range, 10\u201318] hours; P &amp;lt; .001). The risk of endocarditis decreased with 11% per hour (odds ratio [OR], 0.89 [95% confidence interval {CI}, .54\u2013.92]; P &amp;lt; .001) in a univariate analysis using TTP as a continuous variable. In multivariate analysis, TTP &amp;lt;13 hours (the median) was independently associated with endocarditis (OR, 3.59 [95% CI, 2.35\u20135.3]; P &amp;lt; .001). The negative predictive value of TTP &amp;gt;13 hours for endocarditis was 96% (95% CI, 95%\u201397%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Short TTP was associated with endocarditis. The negative predictive value of &amp;gt;95% suggests that TTP &amp;gt;13 hours can be used to risk-stratify patients with SAB.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae628","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T20:33:40Z","timestamp":1734640420000},"page":"727-734","source":"Crossref","is-referenced-by-count":16,"title":["Time to <i>Staphylococcus aureus<\/i> Blood Culture Positivity as a Risk Marker of Infective Endocarditis: A Retrospective Cohort Study"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1712-1215","authenticated-orcid":false,"given":"Martin","family":"Str\u00f6mdahl","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Danderyd Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital , Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5965-6130","authenticated-orcid":false,"given":"Karl","family":"Hagman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital"},{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Hedman","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Westman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Danderyd Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Microbiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8539-9820","authenticated-orcid":false,"given":"Magnus","family":"Hedenstierna","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Danderyd Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital , Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-9327","authenticated-orcid":false,"given":"Johan","family":"Ursing","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Danderyd Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital , Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"2025043020394830400_ciae628-B1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2025043020394830400_ciae628-B2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025043020394830400_ciae628-B3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2025043020394830400_ciae628-B4","doi-asserted-by":"crossref","first-page":"1197.e9","DOI":"10.1016\/j.cmi.2023.05.031","article-title":"Increasing numbers and complexity of Staphylococcus aureus bloodstream infection-14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findings","volume":"29","author":"Math\u00e9","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025043020394830400_ciae628-B5","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/cid\/ciz112","article-title":"Changing characteristics of Staphylococcus aureus bacteremia: results from a 21-year, prospective, longitudinal study","volume":"69","author":"Souli","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025043020394830400_ciae628-B6","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"2025043020394830400_ciae628-B7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","article-title":"A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2025043020394830400_ciae628-B8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2016.02.003","article-title":"The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia","volume":"72","author":"Tubiana","year":"2016","journal-title":"J Infect"},{"key":"2025043020394830400_ciae628-B9","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025043020394830400_ciae628-B10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025043020394830400_ciae628-B11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciz257","article-title":"Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes","volume":"70","author":"Minejima","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025043020394830400_ciae628-B12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/civ235","article-title":"Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia","volume":"61","author":"Palraj","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025043020394830400_ciae628-B13","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/jac\/dkac129","article-title":"Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia","volume":"77","author":"Simos","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2025043020394830400_ciae628-B14","first-page":"114","article-title":"The association between time to positivity and Staphylococcus aureus bacteremia in a geriatric population","volume":"1","author":"Maillart","year":"2012","journal-title":"J Med Microb Diagn"},{"key":"2025043020394830400_ciae628-B15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1086\/432472","article-title":"Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection","volume":"41","author":"Khatib","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025043020394830400_ciae628-B16","doi-asserted-by":"crossref","first-page":"1345.e7","DOI":"10.1016\/j.cmi.2020.11.007","article-title":"Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis","volume":"27","author":"Kahn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025043020394830400_ciae628-B17","doi-asserted-by":"crossref","first-page":"e0266869","DOI":"10.1371\/journal.pone.0266869","article-title":"Bacterial DNA load in Staphylococcus aureus bacteremia is significantly higher in intravascular infections","volume":"17","author":"Nieman","year":"2022","journal-title":"PLoS One"},{"key":"2025043020394830400_ciae628-B18","doi-asserted-by":"crossref","first-page":"ofz126","DOI":"10.1093\/ofid\/ofz126","article-title":"Prognostic power of pathogen cell-free DNA in Staphylococcus aureus bacteremia","volume":"6","author":"Guimaraes","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025043020394830400_ciae628-B19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cmi.2018.07.015","article-title":"Time to blood culture positivity: an independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia","volume":"25","author":"Sim\u00e9on","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2025043020394830400_ciae628-B20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"key":"2025043020394830400_ciae628-B21","doi-asserted-by":"crossref","first-page":"e00317-20","DOI":"10.1128\/AAC.00317-20","article-title":"Early oral antibiotic switch for Staphylococcus aureus bacteremia: many are called, but few are chosen","volume":"64","author":"Holland","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025043020394830400_ciae628-B22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(23)00756-9","article-title":"Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial","volume":"24","author":"Kaasch","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025043020394830400_ciae628-B23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/ciy916","article-title":"Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study","volume":"69","author":"Willekens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025043020394830400_ciae628-B24","doi-asserted-by":"crossref","first-page":"e02345-19","DOI":"10.1128\/AAC.02345-19","article-title":"Efficacy of early oral switch with \u03b2-lactams for low-risk Staphylococcus aureus bacteremia","volume":"64","author":"Bupha-Intr","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025043020394830400_ciae628-B25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2025043020394830400_ciae628-B26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2025043020394830400_ciae628-B27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care\u2014associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"2025043020394830400_ciae628-B28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1469-0691.2007.01736.x","article-title":"Microbial and clinical determinants of time-to-positivity in patients with bacteraemia","volume":"13","author":"Mart\u00ednez","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"2025043020394830400_ciae628-B29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cmi.2017.04.025","article-title":"Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis","volume":"23","author":"Bai","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2025043020394830400_ciae628-B30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MD.0b013e318289ff1e","article-title":"Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates","volume":"92","author":"Chong","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"2025043020394830400_ciae628-B31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/cid\/ciab201","article-title":"Comparable outcomes of short-course and prolonged-course therapy in selected cases of methicillin-susceptible Staphylococcus aureus bacteremia: a pooled cohort study","volume":"73","author":"Thorlacius-Ussing","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025043020394830400_ciae628-B32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2013.10.015","article-title":"Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies","volume":"68","author":"Kaasch","year":"2014","journal-title":"J Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae628\/61252249\/ciae628.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/727\/61252249\/ciae628.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/727\/61252249\/ciae628.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:39:59Z","timestamp":1746059999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/4\/727\/7930161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,21]]},"published-print":{"date-parts":[[2025,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae628","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,15]]},"published":{"date-parts":[[2024,12,21]]}}}